1.94 million Baht and gain on commodity swap agreements was 1.97 million baht 5. In conclusion, for the 2nd quarter of year 2017, the company had net profit after tax of 27.75 million Baht or 0.28 Baht
0.02%. Profit For Q1/2019, Total consolidated net profit (attributable to owners of the Company) advanced to Baht 35.46 million, a 52.96% decrease or Baht 39.92 million over Q1/2018 Because of Gain
and higher in interest rate.. 4. In the 1st quarter, other revenues was 0.36million Baht. Foreign exchange gain was 21.74 million Baht which mainly due to the strengthening of local currency and gain on
interest rate. 4. In the 3rd quarter, other revenues was 2.88 million Baht. Foreign exchange gain was 12.98 million Baht which mainly due to the strenghthen of local currency and gain on commodity swap
estate while the cost of infrastructure service decreases. ▪ In 2018, one subsidiary recognized the gain on disposal of investment in Ngam-Ngum 3 project for THB 14.56 million while no such gain in 2019
be a potential market in the future. For Medical Devices; There is still intense competition in both domestic and foreign markets. Market leaders use price strategies to gain market share. But the
Expenses (35,525) (30,541) (1,092) (923) (36,617) (31,464) 5,153 16% Share of Profit (Loss) 5,972 7,264 84 65 6,056 7,329 (1,273) (17%) Gain on disposal of investments 14,177 - - - 14,177 - 14,177 100
Gain on investments 29.38 - 37.99 - Gain on exchange rate - - 36.75 - Other income 8.17 7.29 13.95 16.93 EXPENSES (145.79) (136.22) (231.42) (239.51) Cost of sales electricity (39.30) (39.29) (78.06
40,522.7 41,059.4 41,849.0 43,575.1 Total Revenues Million Baht 7,518.8 6,003.9 7,981.7 7,681.7 Cost of Goods Sold Million Baht 2,581.9 2,519.8 2,934.6 2,588.0 Net Profit Million Baht 4,903.6 4,500.8 5,202.0
Net Profit less extraordinary items less tax adjusted inventory gain/loss. Net Operating Debt is Net Debt (total debt less cash and current investments) less cash outflow for the various projects